Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
Mais filtros

Medicinas Complementares
Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Clin Lab ; 70(4)2024 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-38623672

RESUMO

BACKGROUND: Vitamin K deficiency can lead to severe coagulation dysfunction, which may be dangerous and fatal, especially in patients undergoing surgery. METHODS: We report an 84-year-old male patient with gallstones and cholecystitis who had a severe coagulation disorder without bleeding symptoms after endoscopic papillary balloon dilation for removal of bile duct stones. After vitamin K supplementation, the coagulation dysfunction was corrected the next day. RESULTS: In this case, long-term antibiotic treatment, inadequate diet, and abnormal liver function led to coagulation dysfunction. After vitamin K supplementation, the blood coagulation disorder was corrected and serious consequences were prevented. Significantly elevated coagulation function was considered to be caused by vitamin K deficiency. CONCLUSIONS: This case indicates that coagulation dysfunction caused by vitamin K deficiency may occur within a few days. Laboratory personnel should fully understand the risks of vitamin K deficiency in elderly patients undergoing surgery with severely restricted diet, impaired absorption, and long-term use of cephalosporin anti-inflammatory therapy, and promptly remind clinical doctors.


Assuntos
Transtornos da Coagulação Sanguínea , Cálculos Biliares , Deficiência de Vitamina K , Masculino , Humanos , Idoso , Idoso de 80 Anos ou mais , Deficiência de Vitamina K/complicações , Vitamina K/uso terapêutico , Cálculos Biliares/complicações , Cálculos Biliares/tratamento farmacológico , Antibacterianos/uso terapêutico
2.
ACS Appl Bio Mater ; 4(5): 3773-3785, 2021 05 17.
Artigo em Inglês | MEDLINE | ID: mdl-35006807

RESUMO

Cholelithiasis with chronic cholecystitis is prevalent and threatens human health. Most cholecystitis caused by bacterial infection or biofilms is accompanied by gallstones in the clinic, making gallbladder removal the only effective solution. Here, we provide a strategy to eliminate gallstone biofilms and dissolve gallstones by oral administration of a supernatant derived from nanoscale iron sulfide (nFeS supernatant). First, by using gallstones obtained from the clinic, we simulated biofilm formation on gallstones and tested the antibacterial activity of a nFeS supernatant in vitro. We found that the supernatant kills bacteria with a 5-log reduction in viability and destroys the biofilm structure. Smashed gallstones coincubated with E. coli biofilms promote gallstone formation, while nFeS supernatant can inhibit this process. Second, by using a murine (C57BL/6) model of cholelithiasis and cholecystitis, we tested the antibacterial efficacy and therapeutic effects of nFeS supernatant on cholelithiasis in vivo. Animal experimental data show that oral administration of nFeS supernatant can reduce 60% of bacteria in the gallbladder and, remarkably, remove gallstones with 2 days of treatment compared with clinical drug combinations (chenodeoxycholid acid and ciprofloxacin). Third, by performing protein abundance analysis of L02 cells and mouse livers, we observed the changes in CYP7a1, HMGCR, and SCP2 expression, indicating that the nFeS supernatant can also regulate cholesterol metabolism to prevent gallstone formation. Finally, hematologic biochemistry analysis and high-throughput sequencing technology show that the nFeS supernatant possesses high biocompatibility. Therefore, our work demonstrates that the nFeS supernatant may be a potential regimen for the treatment of cholelithiasis and cholecystitis by oral administration.


Assuntos
Antibacterianos/farmacologia , Materiais Biocompatíveis/farmacologia , Colecistite/tratamento farmacológico , Compostos Ferrosos/farmacologia , Cálculos Biliares/tratamento farmacológico , Nanopartículas/química , Administração Oral , Animais , Antibacterianos/administração & dosagem , Materiais Biocompatíveis/administração & dosagem , Biofilmes/efeitos dos fármacos , Linhagem Celular , Colecistite/microbiologia , Doença Crônica , Modelos Animais de Doenças , Escherichia coli/efeitos dos fármacos , Compostos Ferrosos/administração & dosagem , Cálculos Biliares/microbiologia , Humanos , Masculino , Teste de Materiais , Camundongos , Camundongos Endogâmicos C57BL , Testes de Sensibilidade Microbiana , Nanopartículas/administração & dosagem , Tamanho da Partícula
3.
Cell Cycle ; 18(23): 3337-3350, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31599189

RESUMO

Gallbladder cancer (GBC) is the common malignancy of the bile tract system with extremely poor clinical outcomes, owing to its metastatic property and intrinsic resistance to the first-line drugs. Although it is well-established that cholesterol abnormity contributes to gallstone formation, a leading risk factor for GBC, the link of cholesterol homeostasis with GBC has not been investigated. The present study systematically examined the genes implicated in cholesterol homeostasis, and revealed altered gene expressions of de novo cholesterol biosynthesis and sterol sulfonation (SULT2B1), reduced bile acid synthesis (CYP7B1 and CYP39A1) and impaired sterol efflux (ABCA1, ABCG5, LCAT, and CETP) in GBC tissues. Suppression of cholesterol biosynthesis by lovastatin inhibited GBC cell proliferation possibly through attenuating the DNA repair process. Further investigation revealed lovastatin sensitized GBC cells to cisplatin-induced apoptosis and suppressed the activation of CHK1, CHK2, and H2AX during DNA damage response. By using chemically distinct statins, HMGCR depletion or supplementing mevalonate, the product of HMGCR, we showed the inhibitory effects on DNA repair process of lovastatin were due to the blockage of the mevalonate pathway. Subcutaneous xenograft mice model suggested lovastatin promoted the therapeutic efficacy of cisplatin, and significantly prolonged the survival times of tumor-bearing mice. Moreover, HMGCR ablation repressed tumor growth in vivo, which can be rescued partially by restored expression of HMGCR, suggesting the on-target effects of lovastatin. Therefore, our study provides the clinical relevance of cholesterol homeostasis with GBC progression, and highlights a novel intervention of combined use of lovastatin and cisplatin for GBC.


Assuntos
Colesterol/genética , Cisplatino/efeitos adversos , Neoplasias da Vesícula Biliar/tratamento farmacológico , Cálculos Biliares/tratamento farmacológico , Transportador 1 de Cassete de Ligação de ATP/genética , Membro 5 da Subfamília G de Transportadores de Cassetes de Ligação de ATP/genética , Animais , Apoptose/efeitos dos fármacos , Colesterol/biossíntese , Proteínas de Transferência de Ésteres de Colesterol/genética , Cisplatino/farmacologia , Família 7 do Citocromo P450/genética , Dano ao DNA/efeitos dos fármacos , Reparo do DNA/efeitos dos fármacos , Feminino , Neoplasias da Vesícula Biliar/genética , Neoplasias da Vesícula Biliar/patologia , Cálculos Biliares/genética , Cálculos Biliares/patologia , Xenoenxertos , Humanos , Masculino , Camundongos , Fosfatidilcolina-Esterol O-Aciltransferase/genética , Fatores de Risco , Esteroide Hidroxilases/genética , Sulfotransferases/genética
4.
Sci Rep ; 9(1): 12740, 2019 09 04.
Artigo em Inglês | MEDLINE | ID: mdl-31484954

RESUMO

The increasing prevalence of cholesterol gallstone disease places an economic burden on the healthcare system. To identify novel therapeutics, we assessed the effects of n-3 polyunsaturated fatty acids (PUFA) in combination with UDCA in a mouse model of cholesterol gallstones. Gallstone dissolution, gallbladder wall thickness, mucin gene expression in the gallbladder, and levels of phospholipids, cholesterol, and bile acids in bile and serum were analysed. RNA was extracted from the liver for mRNA sequencing and gene expression profiling. Combination treatment resulted in greater gallstone dissolution compared with the control group, and PUFA and combination treatments reduced the thickness of the gallbladder wall. Expression levels of mucin genes were significantly lower in the UDCA, PUFA, and combination groups. Transcriptome analyses revealed that combination treatment modulated hepatic lipid metabolism. The PUFA and combination groups showed elevated bile phospholipid and bile acid levels and a lower cholesterol saturation index. Combination treatment with PUFA and UDCA dissolves cholesterol gallstones in mice by decreasing mucin production, increasing levels of phospholipids and bile acids in bile, and decreasing cholesterol saturation. Further studies of the therapeutic effects of combination PUFA and UDCA treatment in patients with cholesterol gallstones are warranted.


Assuntos
Colesterol/metabolismo , Ácidos Graxos Ômega-3/administração & dosagem , Cálculos Biliares/tratamento farmacológico , Ácido Ursodesoxicólico/administração & dosagem , Animais , Ácidos e Sais Biliares/metabolismo , Quimioterapia Combinada , Vesícula Biliar/efeitos dos fármacos , Vesícula Biliar/metabolismo , Cálculos Biliares/metabolismo , Humanos , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Fosfolipídeos/metabolismo
5.
J Transl Med ; 17(1): 195, 2019 06 10.
Artigo em Inglês | MEDLINE | ID: mdl-31182117

RESUMO

BACKGROUND: Although methyl-tertiary butyl ether (MTBE) is the only clinical topical agent for gallstone dissolution, its use is limited by its side effects mostly arising from a relatively low boiling point (55 °C). In this study, we developed the gallstone-dissolving compound containing an aromatic moiety, named 2-methoxy-6-methylpyridine (MMP) with higher boiling point (156 °C), and compared its effectiveness and toxicities with MTBE. METHODS: The dissolubility of MTBE and MMP in vitro was determined by placing human gallstones in glass containers with either solvent and, then, measuring their dry weights. Their dissolubility in vivo was determined by comparing the weights of solvent-treated gallstones and control (dimethyl sulfoxide)-treated gallstones, after directly injecting each solvent into the gallbladder in hamster models with cholesterol and pigmented gallstones. RESULTS: In the in vitro dissolution test, MMP demonstrated statistically higher dissolubility than did MTBE for cholesterol and pigmented gallstones (88.2% vs. 65.7%, 50.8% vs. 29.0%, respectively; P < 0.05). In the in vivo experiments, MMP exhibited 59.0% and 54.3% dissolubility for cholesterol and pigmented gallstones, respectively, which were significantly higher than those of MTBE (50.0% and 32.0%, respectively; P < 0.05). The immunohistochemical stains of gallbladder specimens obtained from the MMP-treated hamsters demonstrated that MMP did not significantly increase the expression of cleaved caspase 9 or significantly decrease the expression of proliferation cell nuclear antigen. CONCLUSIONS: This study demonstrated that MMP has better potential than does MTBE in dissolving gallstones, especially pigmented gallstones, while resulting in lesser toxicities.


Assuntos
Cálculos Biliares/tratamento farmacológico , Fármacos Gastrointestinais/administração & dosagem , Piridinas/administração & dosagem , Solventes/administração & dosagem , Administração Tópica , Animais , Células CHO , Células Cultivadas , Chlorocebus aethiops , Cricetinae , Cricetulus , Avaliação Pré-Clínica de Medicamentos/métodos , Embrião não Mamífero , Feminino , Cálculos Biliares/patologia , Fármacos Gastrointestinais/efeitos adversos , Humanos , Mesocricetus , Camundongos , Camundongos Endogâmicos ICR , Células NIH 3T3 , Piridinas/efeitos adversos , Solventes/efeitos adversos , Células Vero , Peixe-Zebra
7.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 36(11): 1369-1372, 2016 Nov.
Artigo em Chinês | MEDLINE | ID: mdl-30641633

RESUMO

Objective To observe the effect of Shengqing Capsule (SC) on serum contents of TC, LDL-C, and HDL-C, hepatic scavenger receptor B I (SRB I ) , and CD36 in rats with cholesterol cal- culus. Methods Totally 80 mice were divided into 4 groups according to random number table, i.e., the normal group, the model group, the Western medicine (WM) group, and the Chinese medicine (CM) group, 20 in each group. Mice in the normal group were fed with common forage, while mice in the other 3 groups were fed with lithogenic diet. Mice in the CM group and the WM group were fed with SC (at the daily dose of 0.35 g/kg) and Ursodeoxycholic Acid Tablet (UDCA, at the daily dose of 39. 55 mg/kg) re- spectively for 7 weeks. The general condition and gallstone formation rate were observed. Serum contents of TC, LDL-C, and HDL-C, and protein expressions of SBR I and CD36 were detected by oxidase meth- od and Western blot respectively. Results No gallbladder stone formed in the normal group, and gall- stone formed in 15 mice of the model group with gallstone formation rate of 75%. Compared with the nor- mal group, serum contents of TC and LDL-C and protein expressions of SRB I and CD36 increased, HDL-C content decreased in the model group (P <0. 01). The gallstone formation rate was 35% (7 mice) in the WM group and 30% (6 mice) in the CM group, lower than that of the model group (75%; P <0. 05). Contents of TC and LDL-C, and protein expressions of SRB I and CD36 decreased, HDL-C content in- creased in the WM group and the CM group (P <0.01). Compared with the WM group, TC content and protein expressions of SRB I and CD36 decreased in the CM group (P <0.01). Conclusion SC could prevent and treat gallbladder stone possibly through lowering expression levels of SRB I and CD36.


Assuntos
Colesterol , Medicamentos de Ervas Chinesas , Cálculos Biliares , Receptores Depuradores , Animais , Cálculos , Colesterol/sangue , Medicamentos de Ervas Chinesas/farmacologia , Cálculos Biliares/tratamento farmacológico , Cálculos Biliares/prevenção & controle , Camundongos , Ratos , Receptores Depuradores/efeitos dos fármacos
8.
Basic Clin Pharmacol Toxicol ; 118(6): 499-502, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26617265

RESUMO

The endogenous oxysterol 4ß-hydroxycholesterol may be used as a marker for the drug-metabolizing enzymes cytochrome P450 3A (CYP3A). The primary aim of this study was to investigate the effect of statin treatment on plasma 4ß-hydroxycholesterol concentrations. Plasma samples from a previously performed clinical study where gallstone patients had been treated with placebo (n = 6), 20 mg fluvastatin (n = 9) or 80 mg atorvastatin (n = 9) daily for 4 weeks were analysed. Hepatic CYP3A mRNA levels had previously been shown to be unchanged in all three treatment groups. Plasma 4ß-hydroxycholesterol did not change significantly (p = 0.92) in the placebo group, but treatment with low-dose fluvastatin or high-dose atorvastatin resulted in reductions in plasma concentration of 10.7% (p < 0.05) and 36.5% (p < 0.01), respectively. However, the 4ß-hydroxycholesterol/cholesterol ratio did not change significantly for the patients receiving placebo or patients receiving low-dose fluvastatin. The ratio for patients receiving high-dose atorvastatin increased by 12% (p < 0.05). In conclusion, the total plasma cholesterol level is an important determinant for the plasma 4ß-hydroxycholesterol level.


Assuntos
Atorvastatina/farmacologia , Colesterol/sangue , Citocromo P-450 CYP3A/metabolismo , Ácidos Graxos Monoinsaturados/farmacologia , Cálculos Biliares/tratamento farmacológico , Hidroxicolesteróis/sangue , Indóis/farmacologia , Atorvastatina/uso terapêutico , Biomarcadores/sangue , Interações Medicamentosas , Ácidos Graxos Monoinsaturados/uso terapêutico , Feminino , Fluvastatina , Humanos , Inibidores de Hidroximetilglutaril-CoA Redutases , Indóis/uso terapêutico , Masculino , Pessoa de Meia-Idade , Suécia
9.
Zhongguo Zhong Yao Za Zhi ; 40(11): 2106-11, 2015 Jun.
Artigo em Chinês | MEDLINE | ID: mdl-26552164

RESUMO

Lysimachiae Herba and Desmodii Styracifolii Herba are common traditional Chinese medicines for treating lithiasis. Both of them have efficacies of clearing heat, diuresis and eliminating calculi. However, there are some differences in their clinic applications. The former is mainly used to treat hepatolithiasis, gallstones, jaundice, stranguria and gout; Whereas the latter is mainly used to treat urinary calculus. In this paper, the pharmacological effects of Lysimachiae Herba and Desmodii Styracifolii Herba on removing calculus, choleresis, anti-inflammation and oxidation resistance were compared and analyzed based on document retrieval. In conclusion, both of them show the preventive and therapeutic effects on kidney stones and gallstones. Particularly, Desmodii Styracifolii Herba has a better effect in treating the kidney stones, while Lysimachiae Herba has a better effect in treating cholesterol gallstones.


Assuntos
Medicamentos de Ervas Chinesas/farmacologia , Fabaceae , Medicina Tradicional Chinesa , Primulaceae , Medicamentos de Ervas Chinesas/uso terapêutico , Cálculos Biliares/tratamento farmacológico , Humanos , Cálculos Renais/tratamento farmacológico , Fitoterapia
10.
J Ethnopharmacol ; 166: 102-8, 2015 May 26.
Artigo em Inglês | MEDLINE | ID: mdl-25794804

RESUMO

ETHNOPHARMACOLOGICAL RELEVANCE: Whole herb of Lysimachia christinae has long been used as a remedy for cholelithiasis extensively in China. This study was aimed to validate the effect of L. christinae on eliminating preestablished cholesterol gallstone (CGS) in model animals. MATERIALS AND METHODS: Acute toxicity of aqueous extract of L. christinae (LCAE) was estimated in male C57BL/6 mice, so was the efficiency of LCAE on preformed CGS induced by lithogenic diet. The effects of LCAE were also examined on bile secretion rate, the lipid profiles of bile and serum, body weight, main visceral organ indexes, and histomorphology of main visceral organs. RESULTS: Single dose of LCAE did not lead to death and changes on body weight gain, main visceral organ indexes, histomorphology of main visceral organs, and blood hemogram and biochemical indexes, even at dose of 50g material/kg body weight. Preestablished CGSs were almost entirely eliminated after administration of LCAE for 2wk at high dose or for 4wk at low dose. LCAE promoted bile secretion and lowered cholesterol levels in either cystic bile or hepatic bile. LCAE also decreased serum cholesterol content, especially LDL-C content, tremendously, reduced the levels of serum HDL-C, phospholipid, and triglycerine a little, and lowered body weight and liver index significantly. After medication of LCAE for 8wk , neither visceral indexes nor histomorphology of heart, kidney, and spleen were influenced, but fatty degeneration of liver induced by high fat and high cholesterol diet was reverted. CONCLUSION: L. christinae can be considered as non-toxic. It showed prominent efficiency of eliminating preexisted CGS in mice and indicated a hypolipidaemic effect.


Assuntos
Colesterol/metabolismo , Cálculos Biliares/tratamento farmacológico , Extratos Vegetais/farmacologia , Primulaceae/química , Animais , Bile/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Dieta , Modelos Animais de Doenças , Coração/efeitos dos fármacos , Rim/efeitos dos fármacos , Rim/metabolismo , Metabolismo dos Lipídeos/efeitos dos fármacos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Fosfolipídeos/sangue , Extratos Vegetais/química , Baço/efeitos dos fármacos , Baço/metabolismo
11.
Phytother Res ; 28(2): 167-71, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23495001

RESUMO

Raphanus sativus L. var niger (black radish) is a plant of the cruciferous family with important ethnobotanical uses for the treatment of gallstones in Mexican traditional medicine. It has been established that the juice of black radish decreases cholesterol levels in plasma and dissolves gallstones in mice. Glucosinolates, the main secondary metabolites of black radish, can hydrolyze into its respective isothiocyanates and have already demonstrated antioxidant properties as well as their ability to diminish hepatic cholesterol levels; such therapeutic effects can prevent the formation of cholesterol gallstones. This disease is considered a current problem of public health. In the present review, we analyze and discuss the therapeutic effects of the main glucosinolates of black radish, as well as the effects that this plant has on cholesterol gallstones disease.


Assuntos
Anticolesterolemiantes/farmacologia , Colesterol/química , Cálculos Biliares/prevenção & controle , Compostos Fitoquímicos/química , Raphanus/química , Animais , Antioxidantes/farmacologia , Cálculos Biliares/tratamento farmacológico , Glucosinolatos/farmacologia , Humanos , Imidoésteres/farmacologia , Isotiocianatos/farmacologia , Fígado/efeitos dos fármacos , Medicina Tradicional , Camundongos , Oximas , Extratos Vegetais/farmacologia , Sulfóxidos
12.
Food Funct ; 4(1): 116-20, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23051744

RESUMO

Although ginseng, the root of Panax quinquefolium and P. ginseng, was reported to have anti-cholelithogenic effects in animal experiments, there have, to date, been no human studies. We conducted this prospective, controlled, double-blind pilot trial to evaluate the safety and efficiency of Korean red ginseng (KRG), the steamed root of P. ginseng C.A. Meyer. Twenty eight consecutive patients were randomized to receive either KRG (7.5 g divided into three daily doses) or a placebo as an adjuvant to the standard regimen of bile acids for gallstones (500 mg of chenodeoxycholic acid and 500 mg of ursodeoxycholic acid divided into three daily doses) for 24 weeks. No case of serious adverse reaction occurred in both groups. Although the decrease in stone burden was larger in the KRG group (3.4 ± 0.6 ml3) than in the placebo group (2.3 ± 1.1 ml(3)), it did not reach statistical significance (p = 0.09). Also there were no differences in the rate of complete dissolution, subjective improvement in symptoms, and the rate of cholecystectomy due to worsening pain or the development of complications and changes in laboratory tests before and after treatment. In conclusion, the addition of KRG as an adjuvant was safe for patients undergoing bile acid dissolution therapy for gallstones although it did not affect the results. Large-scaled trials to optimize regimens are expectantly needed.


Assuntos
Ácidos e Sais Biliares/farmacologia , Cálculos Biliares/tratamento farmacológico , Panax/química , Idoso , Método Duplo-Cego , Humanos , Pessoa de Meia-Idade , Projetos Piloto
13.
J Biomed Biotechnol ; 2012: 161205, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23093836

RESUMO

In Mexico, Raphanus sativus L. var. niger (black radish) has uses for the treatment of gallstones and for decreasing lipids serum levels. We evaluate the effect of juice squeezed from black radish root in cholesterol gallstones and serum lipids of mice. The toxicity of juice was analyzed according to the OECD guidelines. We used female C57BL/6 mice fed with a lithogenic diet. We performed histopathological studies of gallbladder and liver, and measured concentrations of cholesterol, HDL cholesterol and triglycerides. The juice can be considered bioactive and non-toxic; the lithogenic diet significantly induced cholesterol gallstones; increased cholesterol and triglycerides levels, and decreased HDL levels; gallbladder wall thickness increased markedly, showing epithelial hyperplasia and increased liver weight. After treatment with juice for 6 days, cholesterol gallstones were eradicated significantly in the gallbladder of mice; cholesterol and triglycerides levels decreased too, and there was also an increase in levels of HDL (P < 0.05). Gallbladder tissue continued to show epithelial hyperplasia and granulocyte infiltration; liver tissue showed vacuolar degeneration. The juice of black radish root has properties for treatment of cholesterol gallstones and for decreasing serum lipids levels; therefore, we confirm in a preclinical study the utility that people give it in traditional medicine.


Assuntos
Cálculos Biliares/diagnóstico , Cálculos Biliares/tratamento farmacológico , Hiperlipidemias/diagnóstico , Hiperlipidemias/tratamento farmacológico , Extratos Vegetais/administração & dosagem , Raphanus/química , Administração Oral , Animais , Relação Dose-Resposta a Droga , Feminino , Cálculos Biliares/sangue , Hiperlipidemias/sangue , Hipolipemiantes/administração & dosagem , Lipídeos/administração & dosagem , Camundongos , Camundongos Endogâmicos C57BL , Resultado do Tratamento
14.
World J Gastroenterol ; 16(13): 1555-7, 2010 Apr 07.
Artigo em Inglês | MEDLINE | ID: mdl-20355232

RESUMO

Obesity is associated with insulin resistance, non-alcoholic fatty liver disease (NAFLD) and gallstones.High fat diets (unsaturated fats) rich in cholesterol have been demonstrated to produce not only gallstones but also NAFLD and insulin resistance. Interestingly, a high incidence of gallstones is being reported in association with insulin resistance and NAFLD. Laparoscopic cholecystectomy is the best definitive therapy for symptomatic gallbladder disease. Ezetimibe is a drug that inhibits the absorption of both dietary and biliary cholesterol in the small intestine. Importantly, ezetimibe showed potential benefit not only in treating and preventing gallstones but also in insulin resistance and NAFLD. Further studies are required before the use of ezetimibe for the treatment of gallstones can be advocated.


Assuntos
Anticolesterolemiantes/uso terapêutico , Azetidinas/uso terapêutico , Colesterol/metabolismo , Cálculos Biliares/tratamento farmacológico , Animais , Ensaios Clínicos como Assunto , Dieta , Avaliação Pré-Clínica de Medicamentos/métodos , Ezetimiba , Fígado Gorduroso/tratamento farmacológico , Humanos , Resistência à Insulina , Intestino Delgado/efeitos dos fármacos
15.
Zhong Xi Yi Jie He Xue Bao ; 7(12): 1159-63, 2009 Dec.
Artigo em Chinês | MEDLINE | ID: mdl-20015438

RESUMO

OBJECTIVE: To observe the effects of Yanggan Lidan Granule (YGLDG), a compound traditional Chinese herbal medicine, on insulin resistance in guinea pigs with induced cholesterol gallstones. METHODS: Eighty guinea pigs were randomly divided into normal control group, untreated group, YGLDG group and ursodeoxycholic acid (UDCA) group, with 20 guinea pigs in each group. Except the normal control group, gallstones were induced by high-cholesterol diet in the guinea pigs. The guinea pigs in the normal control group and the untreated group were administered with normal saline. UDCA and YGLDG were given to the guinea pigs in the corresponding groups for seven weeks. Eight guinea pigs of each group were used to measure the glucose infusion rate (GIR) by using hyperinsulinemic-euglycemic clamp technique. At the end the guinea pigs were killed and their gallstone formation was observed. RESULTS: The gallstones in guinea pigs were identified as cholesterol stones by qualitative analysis through infrared spectrum. The incidence rate of cholelithiasis of the untreated group was 82.35% . The GIR of guinea pigs in the untreated group was obviously lowered down as compared with the normal control group. Compared with the untreated group, the GIRs of the YGLDG group and the UDCA group were obviously increased, especially in the YGLDG group. CONCLUSION: YGLDG may improve insulin resistance in guinea pigs with cholesterol gallstones by elevating GIR obviously.


Assuntos
Medicamentos de Ervas Chinesas/uso terapêutico , Cálculos Biliares/tratamento farmacológico , Medicina Tradicional Chinesa , Animais , Colesterol , Cobaias , Resistência à Insulina , Distribuição Aleatória
16.
Altern Med Rev ; 14(3): 258-67, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19803550

RESUMO

Cholesterol gallstones are among the most common gastrointestinal disorders in Western societies. Individuals with gallstones may experience various gastrointestinal symptoms and are also at risk of developing acute or chronic cholecystitis. Cholecystectomy is the most frequently recommended conventional treatment for symptomatic gallstones. Bile acids (ursodeoxycholic acid or chenodeoxycholic acid) are also used in some cases to dissolve radiolucent stones, but these drugs can cause gastrointestinal side effects and there is a high rate of stone recurrence after treatment is discontinued. Lithotripsy is used in some cases in conjunction with ursodeoxycholic acid for patients who have a single symptomatic non-calcified gallstone. There is evidence that dietary factors influence the risk of developing cholesterol gallstones. Dietary factors that may increase risk include cholesterol, saturated fat, trans fatty acids, refined sugar, and possibly legumes. Obesity is also a risk factor for gallstones. Dietary factors that may prevent the development of gallstones include polyunsaturated fat, monounsaturated fat, fiber, and caffeine. Consuming a vegetarian diet is also associated with decreased risk. In addition, identification and avoidance of allergenic foods frequently relieves symptoms of gallbladder disease, although it does not dissolve gallstones. Nutritional supplements that might help prevent gallstones include vitamin C, soy lecithin, and iron. In addition, a mixture of plant terpenes (Rowachol) has been used with some success to dissolve radiolucent gallstones. The gallbladder flush is a folk remedy said to promote the passage of gallstones. While minimal scientific evidence supports the efficacy of this treatment, anecdotal reports suggest the gallbladder flush may be beneficial for some people.


Assuntos
Ácido Ascórbico/uso terapêutico , Cálculos Biliares/tratamento farmacológico , Ferro da Dieta/uso terapêutico , Lecitinas/uso terapêutico , Monoterpenos/uso terapêutico , Colesterol/metabolismo , Gorduras na Dieta/efeitos adversos , Combinação de Medicamentos , Comportamento Alimentar , Cálculos Biliares/dietoterapia , Cálculos Biliares/etiologia , Humanos , Distúrbios Nutricionais/complicações , Obesidade/complicações
17.
Guang Pu Xue Yu Guang Pu Fen Xi ; 29(4): 1108-11, 2009 Apr.
Artigo em Chinês | MEDLINE | ID: mdl-19626913

RESUMO

Trace elements in Mongolian medicine Susi-12 for cholecystitis and gallstones were analyzed in order to discuss the relation between Susi-12's drug action and the trace elements. The analysis was carried out using the pressure seal microwave digestion and inductive coupled plasma atomic emission spectrometry (ICP-AES). It was found that the medicine contained great amount of trace elements, especially human-body-needed trace elements, such as Ca, Al, Mg, Fe, Sr, Mn, Zn, Cu etc., whereas heavy metals are very little, e.g. the contents of Pb, Cb, As etc are below the country's limit. The recoveries of standard addition are in the range of 94.63%-106.40%. The relative standard deviation RSD< or =3.35%, and detection limit is < or =0.009 mg x L(-1). It is concluded that Mongolian medicine Susi-12 can effectively control and cure cholecystitis and gallstones, and the effective rate reaches 91.2% to 100%. So the trace elements in Susi-12 must have a close connection with the drug action.


Assuntos
Colelitíase/tratamento farmacológico , Medicamentos de Ervas Chinesas/análise , Cálculos Biliares/tratamento farmacológico , Medicina Tradicional da Mongólia , Oligoelementos/análise , Adulto , Idoso , Medicamentos de Ervas Chinesas/uso terapêutico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Espectrofotometria Atômica
18.
J Gastroenterol Hepatol ; 24(8): 1451-6, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19486450

RESUMO

AIMS: To investigate the relations between the formation of pigment gallstone and the function of the intestinal mucosal barrier, as well as the underlying mechanism. METHODS: Eighty guinea pigs were randomly divided into three groups in which they were respectively given normal diet, gallstone-causing diet, and gallstone-formation diet with a supplementary intestinal mucosal protection compound known as glutamine. The model of pigment gallstone was established after 8 weeks of dietary administration. Indices about the function of the intestinal mucosal barrier and bacterial translocation were measured. Clinical cases were divided into three groups: control, cholesterol gallstone, and pigment gallstone, where the levels of plasma diamine oxidase (DAO), plasma endotoxin and the excretion rates of technetium 99m-diethylene triamine pentaacetic acid (99mTC-DTPA) in the urine of each group were measured. RESULTS: In the pigment gallstone group, the level of plasma DAO and endotoxin, the excretory ratio of lactulose and mannitol in urine, the bacterial translocation ratio in the celiac lymph nodes and the activities of beta-glucuronidase increased comparing to the control group. The gallstone-formation rate for the intestinal mucosal protection group (GLN) decreased, and other indices, except the activity of beta-glucuronidase, were all lower than that of gallstone-formation group. In the clinical experiment, the levels of plasma DAO and endotoxin, as well as the excretory rate of 99mTC-DTPA in urine were higher in the patients with gallstones than that in the control group. CONCLUSIONS: The formation of pigment gallstone was related to the abnormal function of the intestinal mucosal barrier. The abnormality in the function of the intestinal mucosal barrier probably induced the formation of gallstone by a bacterial translocation mechanism.


Assuntos
Translocação Bacteriana , Pigmentos Biliares/metabolismo , Cálculos Biliares/metabolismo , Mucosa Intestinal/metabolismo , Amina Oxidase (contendo Cobre)/sangue , Animais , Translocação Bacteriana/efeitos dos fármacos , Bile/enzimologia , Estudos de Casos e Controles , Colesterol/metabolismo , Modelos Animais de Doenças , Endotoxinas/sangue , Feminino , Cálculos Biliares/tratamento farmacológico , Cálculos Biliares/microbiologia , Glucuronidase/metabolismo , Glutamina/farmacologia , Cobaias , Humanos , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/microbiologia , Lactulose/urina , Linfonodos/microbiologia , Masculino , Manitol/urina , Permeabilidade , Projetos Piloto , Compostos Radiofarmacêuticos/urina , Pentetato de Tecnécio Tc 99m/urina
19.
Zhong Xi Yi Jie He Xue Bao ; 6(8): 856-9, 2008 Aug.
Artigo em Chinês | MEDLINE | ID: mdl-18664357

RESUMO

OBJECTIVE: To observe the effects of Qingdan Capsule (QDC) and Yanggan Lidan Granule (YGLDG), two kinds of compound traditional Chinese herbal medicines, on biochemical parameters in guinea-pigs with pigment gallstones. METHODS: An animal model of pigment gallstones was established in male guinea-pigs by hypodermic injection of lincomycin. The guinea-pigs were randomly divided into blank control group, untreated group, QDC group and YGLDG group. There were 8 guinea-pigs in each group. After ten-day treatment, animals were sacrificed and sampled to calculate the rate of stone formation, total bilirubin (TB), unconjugated bilirubin (UCB) and Ca2+ density in bile of the four groups. RESULTS: In comparison with the untreated group, the rates of stone formation in the QDC and YGLDG groups were significantly decreased (P<0.01). TBIL, UCB and Ca2+ content of bile in both QDC and YGLD groups was also significantly decreased (P<0.05, P<0.01). CONCLUSION: QDC and YGLD have good effects on biochemical changes of animal model of pigment gallstone in reversing the lithogenesity of bile by reducing the content of TB, UCB and Ca2+, hence resulting in clinical treatment and prevention of pigment gallstone disease.


Assuntos
Pigmentos Biliares/metabolismo , Medicamentos de Ervas Chinesas/uso terapêutico , Cálculos Biliares/química , Cálculos Biliares/tratamento farmacológico , Fitoterapia , Animais , Cálcio/metabolismo , Colagogos e Coleréticos/uso terapêutico , Cálculos Biliares/induzido quimicamente , Cobaias , Lincomicina , Masculino , Distribuição Aleatória
20.
Acta Biomater ; 4(5): 1421-6, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18501688

RESUMO

The comb-like copolymers of polycarboxylic acid were synthesized and then reacted with chenodeoxycholic acid (CDCA) to obtain a series of conjugates, MPn-CDCA, where n is the number of the groups of oxyethylene in each graft chain. This was confirmed by infrared spectroscopy and thin-layer chromatography. We investigated the effects of dissolving model cholesterol gallstones with the MPn-CDCA conjugates in phosphate-buffered saline at pH 7.4. The dissolution rates of CDCA, MP40-CDCA, MP30-CDCA, MP20-CDCA and MP10-CDCA were 5.33, 5.717, 17.59, 6.868 and 9.615x10(-7)kgm(-2)s(-1), micellar solubilities were 0.2431, 3.095, 12.972, 5.248 and 5.790kgm(-3) and total resistances were 5.33, 5.717, 17.59, 6.868 and 9.615x10(-7)kgm(-2)s(-1), respectively. These studies suggested that the interfacial resistance was the dominant rate-determining factor in dissolving model cholesterol gallstones. Model cholesterol gallstones could be more effectively dissolved by increasing the steric interactive potential energy of side chains and ensuring that the hydrophilic-lipophilic properties of MP-CDCA are within an appropriate range. The micellar dissolution rates of model cholesterol gallstones by MP20-CDCA were significantly faster than by the other conjugates.


Assuntos
Líquidos Corporais/química , Ácidos Carboxílicos/química , Ácido Quenodesoxicólico/química , Colesterol/química , Cálculos Biliares/química , Ácidos Carboxílicos/uso terapêutico , Ácido Quenodesoxicólico/uso terapêutico , Difusão , Avaliação Pré-Clínica de Medicamentos , Cálculos Biliares/tratamento farmacológico , Humanos , Cinética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA